Effects of anti-microtubule agents on microtubule organization in cells lacking the kinesin-13 MCAK

Cell Cycle

Volumn 7, Issue 14, 2008, Pages 2146-2156

  Hedrick, David G ^a   Stout, Jane R ^a   Walczak, Claire E ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cell cycle; Chemotherapeutic target; Kinesins; Microtubule dynamics; Mitosis

Indexed keywords

ANTINEOPLASTIC AGENT; KINESIN; KINESIN 13 MCAK; MOLECULAR MOTOR; PACLITAXEL; RNA; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; FEMALE; HELA CELL; HUMAN; HUMAN CELL; KNOCKOUT GENE; MICROTUBULE ASSEMBLY; MITOSIS SPINDLE; MOLECULAR DYNAMICS; PROTEIN ASSEMBLY; PROTEIN DEFECT; PROTEIN FAMILY; REGULATORY MECHANISM; RNA INTERFERENCE; SENSITIVITY ANALYSIS;

EID: 47749138578     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.14.6239     Document Type: Article

References (50)

1. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4:253-65.
2. Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003; 22:9075-86.
3. Einzig AI, Wiernik PH, Schwartz EL. Taxol: a new agent active in melanoma and ovarian cancer. Cancer Treatment And Research 1991; 58:89-100.
4. Horwitz SB. Taxol (paclitaxel): mechanisms of action. Ann Oncol 1994; 5:3-6.
5. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56:816-25.
6. Ngan VK, Bellman K, Hill BT, Wilson L, Jordan MA. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine. Mol Pharmacol 2001; 60:225-32.
7. Jordan MA, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by vinca alkaloids. Cancer Res 1991; 51:2212-22.
8. Guastalla J P, 3rd, Dieras V. The taxanes: toxicity and quality of life considerations in advanced ovarian cancer. Brit J Cancer 2003; 89:16-22.
9. Spiller M, Marson P, Perilongo G, Farina M, Carli M, Bisogno G. A case of vinblastine overdose managed with plasma exchange. Pediatr Blood Cancer 2005; 45:344-6.
10. Sauer G, Korner R, Hanisch A, Ries A, Nigg EA, Sillje HH. Proteome analysis of the human mitotic spindle. Mol Cell Proteomics 2005; 4:35-43.
11. Kline-Smith SL, Walczak CE. Mitotic spindle assembly and chromosome segregation: Refocusing on microtubule dynamics. Mol Cell 2004; 15:317-27.
12. Hertzer KM, Ems-McClung SC, Walczak CE. Kin I kinesins: insights into the mechanism of depolymerization. Crit Rev Biochem Mol Biol 2003; 38:453-69.
13. Moore A, Wordeman L. The mechanism, function and regulation of depolymerizing kinesins during mitosis. Trends Cell Biol 2004; 14:537-46.
14. Howard J, Hyman AA. Microtubule polymerases and depolymerases. Curr Opin Cell Biol 2007; 19:31-5.
15. Kinoshita K, Noetzel TL, Arnal I, Drechsel DN, Hyman AA. Global and local control of microtubule destabilization promoted by a catastrophe kinesin MCAK/XKCM1. J Muscle Res Cell Motil 2006; 27:107-14.
16. Cassimeris L, Morabito J. TOGp, the human homolog of XMAP215/Dis1, is required for centrosome integrity, spindle pole organization, and bipolar spindle assembly. Mol Biol Cell 2004; 15:1580-90.
17. Ganem NJ, Compton DA. The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK. J Cell Biol 2004; 166:473-8.
18. Holmfeldt P, Zhang X, Stenmark S, Walczak CE, Gullberg M. CaMKIIgamma-mediated inactivation of the Kin I kinesin MCAK is essential for bipolar spindle formation. Embo J 2005; 24:1256-66.
19. Stout JR, Rizk RS, Kline SL, Walczak CE. Deciphering protein function during mitosis in PtK cells using RNAi. BMC Cell Biol 2006; 7:26.
20. Walczak CE, Gan EC, Desai A, Mitchison TJ, Kline-Smith SL. The microtubule-destabiliz-ing kinesin XKCM1 is required for chromosome positioning during spindle assembly. Curr Biol 2002; 12:1885-9.
21. Andrews PD, Ovechkina Y, Morrice N, Wagenbach M, Duncan K, Wordeman L, Swedlow JR. Aurora B regulates MCAK at the mitotic centromere. Dev Cell 2004; 6:253-68.
22. Kline-Smith SL, Khodjakov A, Hergert P, Walczak CE. Depletion of centromeric MCAK leads to chromosome congression and segregation defects due to improper kinetochore attachments. Mol Biol Cell 2004; 15:1146-59.
23. Maney T, Hunter AW, Wagenbach M, Wordeman L. Mitotic centromere- associated kinesin is important for anaphase chromosome segregation. J Cell Biol 1998; 142:787-801.
24. Lan W, Zhang X, Kline-Smith SL, Rosasco SE, Barrett-Wilt GA, Shabanowitz J, Hunt D F, Walczak CE, Stukenberg PT. Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity. Curr Biol 2004; 14:273-86.
25. Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 2001; 1:109-17.
26. Wood KW, Cornwell WD, Jackson JR. Past and future of the mitotic spindle as an oncology target. Curr Opin Pharmacol 2001; 1:370-7.
27. Aoki S, Ohta K, Yamazaki T, Sugawara F, Sakaguchi K. Mammalian mitotic centromere-associated kinesin (MCAK): a new molecular target of sulfoquinovosylacylglycerols novel antitumor and immunosuppressive agents. Febs J 2005; 272:2132-40.
28. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross D T, Pergamenschikov A, Williams C F, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999; 96:9212-7.
29. Shimo A, Tanikawa C, Nishidate T, Lin ML, Matsuda K, Park JH, Ueki T, Ohta T, Hirata K, Fukuda M, Nakamura Y, Katagiri T. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci 2008; 99:62-70.
30. Nakamura Y, Tanaka F, Haraguchi N, Mimori K, Matsumoto T, Inoue H, Yanaga K, Mori M. Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 2007; 97:543-9.
31. Jordan MA, Toso RJ, Thrower D, Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 1993; 90:9552-6.
32. Jordan MA, Himes RH, Wilson L. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res 1985; 45:2741-7.
33. Yang D, Welm A, Bishop JM. Cell division and cell survival in the absence of survivin. Proc Natl Acad Sci USA 2004; 101:15100-5.
34. Holmfeldt P, Stenmark S, Gullberg M. Differential functional interplay of TOGp/ XMAP215 and the KinI kinesin MCAK during interphase and mitosis. Embo J 2004; 23:627-37.
35. Zhu C, Zhao J, Bibikova M, Leverson JD, Bossy-Wetzel E, Fan JB, Abraham RT, Jiang W. Functional Analysis of Human Microtubule-based Motor Proteins, the Kinesins and Dyneins, in Mitosis/Cytokinesis Using RNA Interference. Mol Biol Cell 2005; 16:3187-99.
36. Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M, Squire JA. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. Cancer Genet Cytogenet 2003; 144:91-9.
37. Macville M, Schrock E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N, Ried T. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 1999; 59:141-50.
38. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-52.
39. Dhamodharan R, Jordan MA, Thrower D, Wilson L, Wadsworth P. Vinblastine suppresses dynamics of individual microtubules in living interphase cells. Mol Biol Cell 1995; 6:1215-29.
40. Walczak CE, Mitchison TJ, Desai A. XKCM1: A Xenopus kinesin-related protein that regulates microtubule dynamics during mitotic spindle assembly. Cell 1996; 84:37-47.
41. Emanuel SL, Chamberlin HA, Cohen D. Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells. Int J Oncol 1999; 14:487-94.
42. Lee JJ, Swain SM. Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR). Semin Oncol 2005; 32:22-6.
43. Hari M, Loganzo F, Annable T, Tan X, Musto S, Morilla DB, Nettles JH, Snyder JP, Greenberger LM. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules. Mol Cancer Ther 2006; 5:270-8.
44. Wang Y, Yin S, Blade K, Cooper G, Menick DR, Cabral F. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms. Biochemistry 2006; 45:185-94.
45. Hari M, Wang Y, Veeraraghavan S, Cabral F. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine. Mol Cancer Ther 2003; 2:597-605.
46. Kavallaris M, Tait AS, Walsh BJ, He L, Horwitz SB, Norris MD, Haber M. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res 2001; 61:5803-9.
47. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory 1988.
48. Kline-Smith SL, Walczak CE. The microtubule-destabilizing kinesin XKCM1 regulates microtubule dynamic instability in cells. Mol Biol Cell 2002; 13:2718-31.
49. Darzynkiewicz Z. Nucleic Acid Analysis. In: Robinson J, ed. Current Protocols in Cytometry. New York: J Wiley & Sons, Inc 1997.
50. Shapiro H. Practical Flow Cytometry. New York: Alan R. Liss, Inc 1988.